Comcast Corporation (NASDAQ:CMCSA) traded at an unexpectedly high level on 06/16/2017 when the stock experienced a -0.39% loss to a closing price of $41.28. The company saw 26.85 million shares trade hands over the course of the day. Given that its average daily volume over the 30 days has been 17.43 million shares a day, this signifies a pretty significant change over the norm.

Comcast Corporation (CMCSA) Analyst Gushes

Analysts are speculating a 21.12% move, based on the high target price ($50) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $44.9 price target, but the stock is already up 37.51% from its recent lows. However, the stock is trading at -2.13% versus recent highs ($42.18). Analysts believe that we could see stock price minimum in the $33 range (lowest target price), allowing for another -20.06% drop from its current position. Leading up to this report, we have seen a 8.35% rise in the stock price over the last 30 days and a 10.2% increase over the past 3 months. Overall, the share price is up 19.57% so far this year. Additionally, CMCSA had a day price range of $40.68 to $41.35.

Comcast Corporation (CMCSA) Price Potential

Heading into the stock price potential, Comcast Corporation needs to grow just 9.01% to cross its median price target of $45. Given that liquidity is king in short-term, CMCSA is a stock with 4.76 billion shares outstanding that normally trades 1.68% of its float. The stock price recently experienced a 5-day gain of 1.45% with 0.62 average true range (ATR). CMCSA has a beta of 1.01 and RSI is 60.64.

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)’s Lead Over its Technicals

On the other hand, Syros Pharmaceuticals, Inc. by far traveled 115.44% versus a 1-year low price of $8.16. The share price was last seen 5.84% higher, reaching at $17.58 on Jun. 16, 2017. At recent session, the prices were hovering between $16.1 and $17.87. This company shares are 16.04% off its target price of $20.4 and the current market capitalization stands at $434.93M. The recent change has given its price a 14.62% lead over SMA 50 and -18.23% deficit over its 52-week high. The stock witnessed 9.26% gains, 10.29% gains and 18.46% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found SYRS’s volatility during a week at 10.1% and during a month it has been found around 8.59%.

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Intraday Metrics

Syros Pharmaceuticals, Inc. (SYRS) exchanged hands at an unexpectedly high level of 0.24 million shares over the course of the day. Noting its average daily volume at 0.04 million shares each day over the month, this signifies a pretty significant change over the norm.

Syros Pharmaceuticals, Inc. Target Levels

The market experts are predicting a 59.27% rally, based on the high target price ($28) for Syros Pharmaceuticals, Inc. shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $20 range (lowest target price). If faced, it would be a 13.77% jump from its current position. Overall, the share price is up 44.57% year to date.